Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.

Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Pfarr E, Gasior T, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, Verma S, EMPEROR-Pooled Trial Committees and Investigators.

Open source

DOI: 10.1016/j.jacadv.2025.102419
Published: 2026-01-01
Container: JACC Adv
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jacadv.2025.102419,
  title = {Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.},
  author = {Dhingra NK and  Butler J and  Anker SD and  Ferreira JP and  Filippatos G and  Pfarr E and  Gasior T and  Nordaby M and  Brueckmann M and  Pocock SJ and  Zannad F and  Packer M and  Verma S and  EMPEROR-Pooled Trial Committees and Investigators.},
  year = {2026},
  journal = {JACC Adv},
  doi = {10.1016/j.jacadv.2025.102419},
  url = {https://doi.org/10.1016/j.jacadv.2025.102419}
}

RIS

TY  - JOUR
TI  - Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.
AU  - Dhingra NK
AU  -  Butler J
AU  -  Anker SD
AU  -  Ferreira JP
AU  -  Filippatos G
AU  -  Pfarr E
AU  -  Gasior T
AU  -  Nordaby M
AU  -  Brueckmann M
AU  -  Pocock SJ
AU  -  Zannad F
AU  -  Packer M
AU  -  Verma S
AU  -  EMPEROR-Pooled Trial Committees and Investigators.
PY  - 2026
JO  - JACC Adv
DO  - 10.1016/j.jacadv.2025.102419
UR  - https://doi.org/10.1016/j.jacadv.2025.102419
ER  -

APA

NK, D., J, B., SD, A., JP, F., G, F., E, P., T, G., M, N., M, B., SJ, P., F, Z., M, P., S, V., & Investigators., E. T. C. A. (2026). Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.. JACC Adv. https://doi.org/10.1016/j.jacadv.2025.102419

Source records

europe-pmc · retrieved 2026-09-26T03:46:24.175Z
hal · retrieved 2026-09-26T03:46:24.219Z